Will the Bayer glyphosate settlement fall apart? Judge says he may reject $10.9 billion Monsanto Roundup agreement, saying future plaintiffs might be hurt

Monsanto Roundup pesticide ap img
[In June] Bayer agreed to pay as much as $10.9 billion to settle close to 100,000 U.S. lawsuits [alleging its Roundup herbicide causes cancer.]

That included $1.25 billion to support a separate class agreement to address potential future litigation. That part of the settlement requires court approval.

“The Court is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion,” Judge Vince Chhabria said in a filing with the United States District Court, Northern District of California.

Bayer had planned on creating an independent panel of scientific experts to help assess whether glyphosate caused cancer.

Editor’s note: Chabria elaborated in his order:

ADVERTISEMENT

Even if it were lawful to delegate this function to the panel, it’s unclear how the delegation proposed here would benefit a class of Roundup users who either have cancer but have not yet sued Monsanto or have not yet developed cancer. Thus far, judges have been allowing these cases to go to juries, and juries have been reaching verdicts in favor of the plaintiffs, awarding significant compensatory and punitive damages. Why would a potential class member want to replace a jury trial and the right to seek punitive damages with the process contemplated by the settlement agreement?

Read the original post

Related article:  Genetic Literacy Project’s Top 6 Stories for the Week, November 14, 2016
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend